Cargando…
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
SIMPLE SUMMARY: Meningioma are the most common primary intracranial tumour, yet gaps in their molecular characterisation persist and effective treatments for aggressive, recurring, high-grade (WHO grade III) meningioma are lacking. The aim of our study was to outline differences in the molecular lan...
Autores principales: | Dunn, Jemma, Lenis, Vasileios P., Hilton, David A., Warta, Rolf, Herold-Mende, Christel, Hanemann, C. Oliver, Futschik, Matthias E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694371/ https://www.ncbi.nlm.nih.gov/pubmed/33167358 http://dx.doi.org/10.3390/cancers12113270 |
Ejemplares similares
-
Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism
por: Dunn, Jemma, et al.
Publicado: (2018) -
Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT
por: Jungwirth, Gerhard, et al.
Publicado: (2019) -
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo
por: Yu, Tao, et al.
Publicado: (2021) -
Organerhalt: Entscheidungskriterien für Patienten mit T3-Larynxkarzinom
por: Dyckhoff, Gerhard, et al.
Publicado: (2022) -
Larynxorganerhalt bis zum T4‑Larynxkarzinom?
por: Dyckhoff, Gerhard, et al.
Publicado: (2022)